Tele-expertise reduces time to diagnosis for cutaneous melanoma.

IF 1.8 4区医学 Q3 DERMATOLOGY

Melanoma Research Pub Date : 2026-08-11 DOI:10.1097/CMR.0000000000001131

Inès Belkasmi, Selma Azib, Hélène Behal, Chloé Vuillamy, Eve Desmedt, Elise Toulemonde, Jean-Matthieu L'Orphelin, Laurent Mortier, Marie Boileau

{"title":"Tele-expertise reduces time to diagnosis for cutaneous melanoma.","authors":"Inès Belkasmi, Selma Azib, Hélène Behal, Chloé Vuillamy, Eve Desmedt, Elise Toulemonde, Jean-Matthieu L'Orphelin, Laurent Mortier, Marie Boileau","doi":"10.1097/CMR.0000000000001131","DOIUrl":null,"url":null,"abstract":"<p><p>Rapid treatment of melanoma is essential to obtain the best possible survival rate, in an epidemiological context that makes access to dermatological care difficult. Tele-expertise (TLE) has rapidly become the most widely practiced form of telemedicine in the world. Since September 2022, TLE has been used in our center. Our objective was to compare the diagnosis time for suspicious pigmented lesions using TLE compared with the classic addressing method (CAM) from September 2022 to December 2023. Two groups were formed based on anatomopathological diagnoses: one group referred through TLE, and the other through CAM. The median delay between the date of consultation request and the date of medical care was assessed in number of days. A total of 160 patients were analyzed. A significant reduction in median diagnosis time was achieved in the TLE group, with a median delay of 23 versus 49 days in the CAM group for all lesions and of 10 versus 28 days for invasive melanomas. The quality of TLE requests was predominantly considered 'good' or 'very good' quality. TLE could be a key solution to the demographic challenges facing dermatology.</p>","PeriodicalId":18550,"journal":{"name":"Melanoma Research","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CMR.0000000000001131","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Rapid treatment of melanoma is essential to obtain the best possible survival rate, in an epidemiological context that makes access to dermatological care difficult. Tele-expertise (TLE) has rapidly become the most widely practiced form of telemedicine in the world. Since September 2022, TLE has been used in our center. Our objective was to compare the diagnosis time for suspicious pigmented lesions using TLE compared with the classic addressing method (CAM) from September 2022 to December 2023. Two groups were formed based on anatomopathological diagnoses: one group referred through TLE, and the other through CAM. The median delay between the date of consultation request and the date of medical care was assessed in number of days. A total of 160 patients were analyzed. A significant reduction in median diagnosis time was achieved in the TLE group, with a median delay of 23 versus 49 days in the CAM group for all lesions and of 10 versus 28 days for invasive melanomas. The quality of TLE requests was predominantly considered 'good' or 'very good' quality. TLE could be a key solution to the demographic challenges facing dermatology.

查看原文本刊更多论文

远程专家缩短了皮肤黑色素瘤的诊断时间。

在流行病学背景下，快速治疗黑色素瘤对于获得尽可能高的存活率至关重要，这使得获得皮肤科护理变得困难。远程专家（TLE）已迅速成为世界上最广泛实施的远程医疗形式。自2022年9月起，我们中心开始使用TLE。我们的目的是比较2022年9月至2023年12月期间，TLE与经典定位方法（CAM）对可疑色素病变的诊断时间。根据解剖病理诊断分为两组：一组通过TLE转诊，另一组通过CAM转诊。从提出咨询请求之日到获得医疗服务之日之间的延迟中位数以天数计算。共分析了160例患者。TLE组的中位诊断时间显著缩短，所有病变的中位延迟时间为23天，而CAM组为49天，浸润性黑色素瘤的中位延迟时间为10天，而CAM组为28天。TLE请求的质量主要被认为是“好”或“非常好”的质量。TLE可能是解决皮肤病学面临的人口统计学挑战的关键解决方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Melanoma Research 医学-皮肤病学

CiteScore

3.40

自引率

4.50%

发文量

139

审稿时长

6-12 weeks

期刊介绍： Melanoma Research is a well established international forum for the dissemination of new findings relating to melanoma. The aim of the Journal is to promote the level of informational exchange between those engaged in the field. Melanoma Research aims to encourage an informed and balanced view of experimental and clinical research and extend and stimulate communication and exchange of knowledge between investigators with differing areas of expertise. This will foster the development of translational research. The reporting of new clinical results and the effect and toxicity of new therapeutic agents and immunotherapy will be given emphasis by rapid publication of Short Communications. Thus, Melanoma Research seeks to present a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma.